Currently out of the existing stock ratings of Andreas Argyrides, 48 are a BUY (75%), 12 are a HOLD (18.75%), 4 are a SELL (6.25%).

Andreas Argyrides

Work Performance Price Targets & Ratings Chart

Analyst Andreas Argyrides works at WEDBUSH with a stock forecast success ratio of 15.62% fulfilled within 63.88 days on average.

Andreas Argyrides’s has documented 127 price targets and ratings displayed on 18 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on RGNX, Regenxbio at 12-Feb-2024.

Wall Street Analyst Andreas Argyrides

Analyst best performing recommendations are on UBX (UNITY BIOTECHNOLOGY).
The best stock recommendation documented was for UBX (UNITY BIOTECHNOLOGY) at 4/25/2023. The price target of $3 was fulfilled within 27 days with a profit of $0.96 (47.06%) receiving and performance score of 17.43.

Average potential price target upside

RGNX Regenxbio UBX Unity Biotechnology ALBO Albireo Pharma ASND Ascendis Pharma AS BMRN Biomarin Pharmaceutical AQST Aquestive Therapeutics SGMO Sangamo Therapeutics AVTE Aerovate Therapeutics KALA Kala Pharmaceuticals UTHR United Therapeutics VRNA Verona Pharma PLC ADR GBT Global Blood Therapeutics GOSS Gossamer Bio IMUX Immunic KROS Keros Therapeutics  LQDA Liquidia Technologies MLTX MoonLake Immunotherapeutics RANI Rani Therapeutics Holdings

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

21

$3.59 (20.62%)

20

12 days ago

2/3 (66.67%)

$3.64 (20.97%)

36

Hold

20

$2.59 (14.88%)

20

4 months 20 days ago

4/9 (44.44%)

$4.84 (31.93%)

50

Buy

42

$24.59 (141.24%)

43

5 months 26 days ago

0/8 (0%)

$23.61 (128.38%)

Buy

55

$37.59 (215.91%)

61

6 months 21 days ago

0/5 (0%)

$37.52 (214.65%)

Buy

42

$24.59 (141.24%)

42

8 months 4 days ago

0/2 (0%)

$21.72 (107.10%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Andreas Argyrides is most bullish on?

Potential upside of $66.8 has been obtained for ASND (ASCENDIS PHARMA AS)

Which stock is Andreas Argyrides is most reserved on?

Potential downside of -$0 has been obtained for UBX (UNITY BIOTECHNOLOGY)

What Year was the first public recommendation made by Andreas Argyrides?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?